Learn more

AMPSOURCE BIOPHARMA SHANGHAI INC

Overview
  • Total Patents
    28
  • GoodIP Patent Rank
    56,740
  • Filing trend
    ⇩ 100.0%
About

AMPSOURCE BIOPHARMA SHANGHAI INC has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are UNUM THERAPEUTICS INC, ICELL GENE THERAPEUTICS LLC and IMMUNEONCO BIOPHARMACEUTICALS SHANGHAI CO LTD.

Patent filings per year

Chart showing AMPSOURCE BIOPHARMA SHANGHAI INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Li Qiang 26
#2 Li Yuanli 20
#3 Ma Xinlu 17
#4 Zheng Yuncheng 16
#5 Xiao Liang 8
#6 Xue Tongtong 8
#7 Liu Dengnian 8
#8 Gao Yongjuan 8
#9 Sun Jianyu 7
#10 Hu Jiangjiang 7

Latest patents

Publication Filing date Title
WO2021012947A1 Fgf21 fc fusion protein, glp-1 fc fusion protein, and combination therapeutic agent comprising same and use thereof
WO2020063562A1 Fusion protein of mutated single-chain human coagulation factor viii, preparation method therefor, and use thereof
CN111886023A Antibodies to TIM-3 and uses thereof
US2020347131A1 Anti-lag-3 antibody and use thereof
KR20190117493A Anti PD-1 Antibodies and Uses thereof
US2019365867A1 Highly glycosylated human blood-clotting factor viii fusion protein, and manufacturing method and application of same
EP3502143A1 Linker peptide for constructing fusion protein